Showing results (211-220 of 314) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|December 24, 2014
Association between KRAS mutation and lung metastasis in advanced colorectal cancerA A L Pereira, J F M Rego, V Morris, et al.JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistanceScott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancerGiacomo Mazzoli, Romain Cohen, Sara Lonardi, et al.The Lancet. Oncology|July 24, 2017
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyMichael J Overman, Ray McDermott, Joseph L Leach, et al.Journal of the National Cancer Institute|May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal CancerJonathan M Loree, Ann M Bailey, Amber M Johnson, et al.Annals of Surgical Oncology|November 12, 2025
Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous NeoplasmsAshlee N Seldomridge, Michael G White, Christopher Scally, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.Clinical Colorectal Cancer|February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal CancerShailesh M Advani, Quilling Shi, Michael J Overman, et al.European Journal of Cancer (Oxford, England : 1990)|December 21, 2021
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancerGiovanni Randon, Rossana Intini, Chiara Cremolini, et al.Pageof 32